These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

764 related items for PubMed ID: 29611079

  • 21. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M, Kornfield R, Vittinghoff E, Inadomi JM, Biggins SW.
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [Abstract] [Full Text] [Related]

  • 22. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database.
    Goldberg DS, Krok K, Batra S, Trotter JF, Kawut SM, Fallon MB.
    Gastroenterology; 2014 May; 146(5):1256-65.e1. PubMed ID: 24412528
    [Abstract] [Full Text] [Related]

  • 23. Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
    Brock GN, Washburn K, Marvin MR.
    PLoS One; 2019 May; 14(10):e0223053. PubMed ID: 31581270
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group.
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [Abstract] [Full Text] [Related]

  • 27. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ, Lai JC, Dodge JL, Roberts JP.
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA, Kuo YF, Asrani S, Wong RJ, Ahmed A, Kwo P, Terrault N, Kamath PS, Jalan R, Singal AK.
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P, Schaubel DE, Messersmith EE, Guidinger MK, Merion RM.
    Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S, Chau LC, Kitajima T, Yeddula S, Collins K, Rizzari M, Yoshida A, Abouljoud MS, Moonka D.
    Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
    [Abstract] [Full Text] [Related]

  • 34. Trends in Characteristics of Patients Listed for Liver Transplantation Will Lead to Higher Rates of Waitlist Removal Due to Clinical Deterioration.
    Yi Z, Mayorga ME, Orman ES, Wheeler SB, Hayashi PH, Barritt AS.
    Transplantation; 2017 Oct; 101(10):2368-2374. PubMed ID: 28858174
    [Abstract] [Full Text] [Related]

  • 35. Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Nobel YR, Goldberg DS.
    Transplantation; 2015 Nov; 99(11):2341-6. PubMed ID: 25989503
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.
    Kim WR, Mannalithara A, Kwo PY, Bonham CA, Kwong A.
    Hepatology; 2023 Mar 01; 77(3):851-861. PubMed ID: 36052665
    [Abstract] [Full Text] [Related]

  • 38. Hypoalbuminemia is Associated With Significantly Higher Liver Transplant Waitlist Mortality and Lower Probability of Receiving Liver Transplant.
    Ahn J, Sundaram V, Ayoub WS, Frenette C, Wong RJ.
    J Clin Gastroenterol; 2018 Mar 01; 52(10):913-917. PubMed ID: 29356783
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 39.